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Absence of Platelet Endothelial Cell Adhesion Molecule 1, PECAM-1/
CD31, In Vivo Increases Resistance to Salmonella enterica Serovar
Typhimurium in Mice
Michael D. Lovelace,a* May Lin Yap,a Jana Yip,a,d William Muller,b Odilia Wijburg,c Denise E. Jackson,a,d
Burnet Institute, Melbourne, Victoria, Australiaa; Northwestern University, Chicago, Illinois, USAb; Department of Microbiology and Immunology, University of Melbourne,
Parkville, Victoria, Australiac; RMIT University, Bundoora, Victoria, Australiad
PECAM-1/CD31 is known to regulate inflammatory responses and exhibit pro- and anti-inflammatory functions. This study was
designed to determine the functional role of PECAM-1 in susceptibility to murine primary in vivo infection with Salmonella
enterica serovar Typhimurium and in in vitro inflammatory responses of peritoneal macrophages. Lectin profiling showed that
cellular PECAM-1 and recombinant human PECAM-1-Ig chimera contain high levels of mannose sugars andN-acetylgluco-
samine. Consistent with this carbohydrate pattern, both recombinant human andmurine PECAM-1-Ig chimeras were shown to
bind S. Typhimurium in a dose-dependent manner in vitro. Using oral and fecal-oral transmission models of S. Typhimurium
SL1344 infection, PECAM-1/mice were found to be more resistant to S. Typhimurium infection than wild-type (WT)
C57BL/6 mice. While fecal shedding of S. Typhimuriumwas comparable in wild-type and PECAM-1/mice, the PECAM-1-
deficient mice had lower bacterial loads in systemic organs such as liver, spleen, andmesenteric lymph nodes thanWTmice, sug-
gesting that extraintestinal dissemination was reduced in the absence of PECAM-1. This reduced bacterial load correlated with
reduced tumor necrosis factor (TNF), interleukin-6 (IL-6), andmonocyte chemoattractant protein (MCP) levels in sera of
PECAM-1/mice. Following in vitro stimulation of macrophages with either whole S. Typhimurium, lipopolysaccharide (LPS)
(Toll-like receptor 4 [TLR4] ligand), or poly(I·C) (TLR3 ligand), production of TNF and IL-6 by PECAM-1/macrophages was
reduced. Together, these results suggest that PECAM-1may have multiple functions in resistance to infection with S. Typhimu-
rium, including binding to host cells, extraintestinal spread to deeper tissues, and regulation of inflammatory cytokine produc-
tion by infected macrophages.
Pathogen recognition by the immune system is crucial for theinduction and maintenance of protective immunity (1).
Rapid clearance of pathogens is essential for successful control of
pyrogenic bacterial infections. Microbial pathogens have devel-
oped a variety of strategies to resist the innate and adaptive im-
mune responses in order to survive and multiply in specific sites
(2). The first step in bacterial recognition and pathogenesis is the
interaction of bacterial structures expressed by the pathogen with
host cell surface receptors, which, depending on the bacterial
pathogen, may lead to bacterial intake by host cells. Bacteria may
use intracellular niches as protection from the immune system
and a safe site for replication and/or dissemination. Salmonella
enterica serovar Typhimurium is a Gram-negative bacterium ca-
pable of evading the immune system by using macrophages as a
protective niche for transport, replication, and survival (3).
The Ig-ITIM superfamily member platelet endothelial cell ad-
hesionmolecule 1 (PECAM-1) negatively regulates hematopoietic
cell function, leukocyte transmigration, immune homeostasis,
thrombosis, cutaneous anaphylaxis, apoptosis, and vascular per-
meability (4–12). Recent studies have suggested that PECAM-1
may also play a role in resistance to bacterial infections in vivo. It
has been demonstrated that PECAM-1 knockout mice are more
susceptible to lipopolysaccharide (LPS) endotoxic shock than
their wild-type (WT) counterparts (13, 14). In addition,
PECAM-1 is constitutively expressed onmacrophages, and its ex-
pression is upregulated by LPS stimulation (15). Ligation of
PECAM-1 with CD38 has been associated with negative regula-
tion of Toll-like receptor 4 (TLR4) signaling inmacrophages (16).
While human CD38 has been proposed as a coreceptor for
PECAM-1, these findings have not been reproduced by studies in
mice, so this issue remains unresolved (17). In addition, while
these earlier studies suggest a role for PECAM-1 as a negative
regulator of LPS-induced inflammatory responses in macro-
phages and endotoxic shock, these studies did not examine viru-
lence factors associatedwith in vivo infectionswithGram-negative
bacteria.
Recent studies suggest that a related Ig-ITIM superfamily
member, carcinoembryonic cell adhesionmolecule 1 (CEACAM-
1), serves as a receptor for bacterial pathogens, including S. Ty-
phimurium, Escherichia coli, Neisseria gonorrhoeae, and Neisseria
meningitidis in humans (18, 19). Based uponmolecularmodeling,
crystallographic, and mutagenesis studies, a central paradigm has
been proposed where the most distal N-terminal IgV-like domain
1 of CEACAM-1 is the target for binding to all currently identified
bacterial ligands (20). However, the interactions between the
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closely related immunoreceptors such as PECAM-1 and bacterial
ligands are less well defined.
In this study, we addressed whether PECAM-1 has the capacity
to interact with the Gram-negative pathogen S. Typhimurium.
We determined the carbohydrate moieties on PECAM-1 with lec-
tin profiling and examined direct binding of S. Typhimurium to
human and mouse recombinant PECAM-1 in vitro. In addition,
to address whether PECAM-1 plays a role in the pathogenesis of S.
Typhimurium infection in vivo, we examined the control of S.
Typhimurium infection in PECAM-1/ mice. Our results indi-
cate that the absence of PECAM-1 resulted in reduced extraintes-
tinal dissemination of S. Typhimurium to systemic sites, resulting
in reduced proinflammatory responses. Further, macrophages
from PECAM-1/ mice are less responsive to TLR ligands in in
vitro stimulations, suggesting that PECAM-1 may play a role in
modulating the innate immune response following microbial ex-
posure. Together, these results suggest that PECAM-1 may have
multiple functions in resistance to infection with S. Typhimu-
rium, including binding to host cells, extraintestinal spread to
deeper tissues, and regulation of inflammatory cytokine produc-
tion by infected macrophages.
MATERIALS AND METHODS
Reagents. S. Typhimurium virulent strain SL1344 was provided by P.
Coloe and P. Smooker (RMIT University, Bundoora, Victoria). The
mouse cytometric bead array (CBA) inflammation kit was obtained from
BDBiosciences (Franklin Lakes, NJ). Cell culture reagents, includingDul-
becco’s modified Eagle medium (DMEM), fetal bovine serum (FBS), 200
mMglutamine, premixed penicillin (100U/ml) and streptomycin (10,000
g/ml), and 1 M HEPES buffer (pH 7.2). were from Gibco (Invitrogen,
Life Technologies). SEW16 anti-humanPECAM-1 antibodywas obtained
from Peter Newman (Blood Research Institute, Milwaukee, WI), anti-
mouse PECAM-1 antibody–fluorescein isothiocyanate (FITC) was pur-
chased from Santa Cruz (Santa Cruz, CA), 4D1C2 anti-CEACAM-1 anti-
body was obtained from Nicole Beauchemin (McGill University,
Montreal, Quebec, Canada), and F4/80 antimacrophage antibody and
streptavidin-phycoerythrin (PE) were obtained from BD Biosciences
(Franklin Lakes, NJ). Salmonella lipopolysaccharide (LPS) was purchased
from Sigma Chemical Co. (St. Louis, MO). CpG, poly(I·C), and Loxorib-
ine (LXR) were obtained from Invivogen (San Diego, CA). Peptidoglycan
(PGN) was purchased from Fluka (Ronkonkoma, NY).
Mice. The construction of PECAM-1/ (PECAM-1 knockout) mice
has been previously described (21). These PECAM-1/mice were back-
crossed eight generations onto the C57BL/6 background. Mice were
housed in a specific-pathogen-free facility at the Burnet Institute animal
house, Heidelberg, Melbourne, Australia. For mouse genotyping, the
primers for PECAM-1 forward (sense oligonucleotide) (5=-ATGGAACT
GGCACCCATCACTTA-3=), PECAM-1 reverse (antisense oligonucleo-
tide) (5=-GGTCACGTCTCGCCTATTAAGC-3=), and neomycin (anti-
sense oligonucleotide) (5=-GTCTTCTTGAGCAGTTCTTCCGCTATC-
3=) were obtained from Sigma Proligo (Castle Hill, New South Wales,
Australia). Age- and sex-matched groups of 6- to 8-week-old wild-type
C57BL/6 and PECAM-1/mice were used for in vitro and in vivo exper-
iments. Wild-type C57BL/6 and PECAM-1/mice were genotyped us-
ing PCR-restriction fragment length polymorphism specific for the gua-
nine-to-adenine pointmutation associated with the susceptibility allele of
the Slc11a1 (Nramp1) gene. Nramp1 primer sequences Ity3= (ACA GCC
CGG ACA GGT GGG), Ity5=S (ACG CAT CCC GCT GTG GGA) (sus-
ceptible or Nramp1/ primer), and Ity5=R (ACG CAT CCC GCT GTG
GGG) (resistant or NRamp1/ primer) were obtained from Sigma Pro-
ligo. Both wild-type and PECAM-1/mice were confirmed to carry the
homozygous susceptible allele of Slc11a1 (Nramp1) by PCR (22). All an-
imal experiments were approved by the Austin Health Animal Ethics
Committee and complied with the Prevention of Cruelty to Animals Act
(1986) and theNationalHealth andMedical ResearchCouncil (NHMRC)
Australian Code of Practice for the Care and Use of Animals for Scientific
Purposes (1997).
Lectin profiling and Western blotting. Platelet lysates were pre-
cleared twicewith 50l of a 50% suspension ofCNBr-activated Sepharose
beads (AmershamPharmacia BiotechAB,Uppsala, Sweden) for 15min at
4°C and then centrifuged at 4,000 rpm for 5min, and the supernatant was
retained. Precleared platelet lysates (1.5mg) were incubated with 10g of
biotin-labeled lectins (Vector Laboratories, Burlingame, CA) at 4°C for 2
h. The lectin-carbohydrate-protein complexes were then isolated with 50
l of a 50% suspension of streptavidin-agarose beads (Sigma Chemical
Company, St. Louis, MO) incubated for 1 h at 4°C. Beads were then
washed five timeswith immunoprecipitation buffer (20mMTris [pH7.4]
containing 50mMNaCl and 2% [vol/vol] Triton X-100). Bound proteins
were eluted from the streptavidin-agarose beads by boiling for 10 min in
30l SDS reducing buffer and resolved on a 10%SDS-polyacrylamide gel,
followed by Western blot analysis using either SEW16 anti-PECAM-1
antibody (20g/ml) ormonoclonal 4D1C2 anti-CEACAM-1 antibody (5
g/ml) and then appropriate horseradish peroxidase (HRP)-conjugated
secondary antibody (1/20,000), followed by ECL detection.
Salmonella enzyme-linked immunosorbent assay (ELISA).Microti-
ter plates (Maxisorp; Nunc, Wiesbaden, Denmark) were coated with 100
l of human recombinant PECAM-1-Ig chimera protein at various doses
(0 to 5 g/ml). PECAM-1-Ig chimera was diluted in 0.2 M carbonate
buffer (pH 8.3), and plates were coated overnight at 4°C. Nonspecific
binding sites were blocked with 200 l of 1% (wt/vol) bovine serum al-
bumin (BSA) (Bovogen Biologicals, Keilor East, Victoria, Australia) in
0.01 M phosphate-buffered saline (PBS) (pH 7.4) for 1 h at 37°C. The
wells werewashed three timeswith 0.01MPBS (pH7.4) containing 0.05%
(vol/vol) Tween 20 (Sigma Chemical Co., St. Louis, MO). Bacteria were
collected from an overnight culture by centrifugation at 2,400 rpm for 30
min and resuspended in blocking buffer, and 100 l of bacterial suspen-
sion was added and incubated for 2 h at 37°C. The wells were washed six
times with wash buffer, and then rabbit anti-Salmonella serumwas added
and incubated for 2 h at 37°C. Wells were washed six times with wash
buffer, and alkaline phosphatase-conjugated sheep anti-rabbit antibody
(Rockland Inc., Gilbertsville, PA) was added to each well and incubated
for 1 h at 37°C. Bound antibodies were visualized using para-nitrophenyl
phosphate (pNPP) as the substrate. The reaction was terminated with 50
l of 2NNaOH, and absorbance at 405 nmwasmeasured using a Fluostar
Optima plate reader (BMG Labtechnologies, Offenburg, Germany).
Bacterial culture and preparation. S. Typhimurium SL1344 was cul-
tured overnight in 10 ml of Luria broth (LB) containing 25 g/ml strep-
tomycin at 37°C with agitation. For in vitro infections, S. Typhimurium
SL1344 was collected from cultures by centrifugation and incubated at
37°C for 30 min in 300 l of 10% (vol/vol) normal mouse serum in
DMEM. Opsonized bacteria were collected by centrifugation at 13,000
rpm for 5 min, and serial dilutions were prepared in incomplete DMEM
for infection of peritoneal macrophages. To heat kill the bacteria, after
opsonization, S. Typhimurium SL1344 was heated at 65°C for 20 min.
Killing of bacteria was confirmed by culture for 48 h on LB-streptomycin
agar at 37°C. The viable count in overnight SL1344 cultures was deter-
mined by plating serial dilutions onto XLD plates and incubating at 37°C
for 24 h.
Oral infection of mice with S. Typhimurium SL1344. Bacteria were
cultured to mid-log growth phase and prepared as described previously
(23). Mice were infected with 0.1 ml containing 103 to 105 CFU S. Typhi-
murium SL1344 by oral gavage under light inhalation anesthesia (22).
Mice were observed for symptoms of salmonellosis and euthanized when
humane endpoints were reached. The clinical symptoms that were mon-
itored included fur condition, alertness, mobility, body weight loss, pos-
ture, and breathing rate.
Natural S. Typhimurium infection model. To mimic the natural fe-
cal-oral route of S. Typhimurium transmission, a single C57BL/6 mouse
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was infected with 1  106 CFU S. Typhimurium SL1344 by oral gavage
and placed in a cage with naive animals (23). The acquisition and devel-
opment of S. Typhimurium infection in the naive cohoused animals
was monitored by detection of S. Typhimurium in fresh fecal samples
plated on selected indicator medium (XLD). The absence of S. Typhi-
murium in feces of all mice was confirmed before commencement of
the experiments (24).
Enumeration of bacterial organ load from infected mice.Mice were
euthanized 5 days after oral infection, and livers, spleens, mesenteric
lymph nodes (MLN), and brains were harvested into 5 ml of sterile cold
PBS. Organs were homogenized using a Stomacher 80 Biomaster homog-
enizer (Seward, United Kingdom) at low speed for 5min. Viable counts in
serial dilutions of homogenates were determined following culture on LB
agar containing 25 g/ml streptomycin (Sigma Chemical Co., St. Louis,
MO) for 24 h at 37°C.
Cytokine analyses.Mouse sera collected at day 5 after infectionwith S.
Typhimurium SL1344 and supernatants collected from in vitro macro-
phage invasion assay were aliquoted and stored at80°C. For analysis of
mouse serum cytokine levels, blood was obtained by cardiac puncture,
incubated at 37°C for 1 h, and then centrifuged at 4,000 rpm for 10min to
separate the serum. Sera and supernatants were analyzed for cytokine
levels using the mouse inflammation cytometric bead array (CBA) assay
kit from BD Biosciences according to the manufacturer’s instructions.
The cytokines analyzed were interleukin-6 (IL-6), interleukin-10 (IL-10),
monocyte chemoattractant protein 1 (MCP-1), gamma interferon (IFN-
), tumor necrosis factor alpha (TNF-), and interleukin-12p70 (IL-
12p70). Data were acquired on a FACSCanto flow cytometer, and cyto-
kine levels were analyzed using the CBA software.
Culturing of murine peritoneal macrophages for flow cytometry
and cytokine analyses.Mouse resident peritonealmacrophageswere har-
vested by intraperitoneal lavage with PBS from six wild-type C57BL/6 and
PECAM-1/mice and cultured in a 1:1 ratio of complete DMEM (sup-
plemented with 10% [vol/vol] heat-inactivated fetal calf serum [FCS], 2
mM glutamine, 50 g/ml penicillin-streptomycin antibiotic, and 15 mM
HEPES, pH 7.2) and 50% L-cell conditioned medium (as a source of
macrophage colony-stimulating factor [M-CSF]). These cells were plated
in 24-well plates at a density of 2  105 cells per well containing 1 ml of
medium and grown at 37°C in a humidified 5% CO2 incubator (Sanyo
Fisher Company, Chatsworth, CA). The culture medium was changed
after 1 day to remove nonadherent cells, and the cells were cultured for 6
days. For analysis of cytokines, the cells were grown for an additional 2
days in the above-described medium before the experiment. Cell viability
was assessed by trypan blue exclusion.
Flow cytometry. Cultured peritoneal macrophages (2.5 105) from
wild-type C57BL/6 and PECAM-1/mice were collected and suspended
in fluorescence-activated cell sorter (FACS) buffer (PBS [pH7.4] contain-
ing 1% [vol/vol] FCS). To prevent nonspecific antibody binding, macro-
phages were incubated with 2.4G2 anti-FcRII antibody (provided by
P. M. Hogarth, Burnet Institute, Heidelberg, Victoria, Australia) before
staining with either anti-F4/80 (biotin conjugated [BD Pharmingen, San
Diego, CA] or PE conjugated [eBioscience, San Diego, CA]), polyclonal
rabbit anti-mouse TLR3/CD283 antibody (Imgenex, San Diego, CA), rat
anti-mouse TLR4 antibody (Santa Cruz Biotechnology Inc., Santa Cruz,
CA), or rat anti-mouse PECAM-1 IgG2a antibody (BD Pharmingen, San
Diego,CA).Goat anti-rat IgG–FITCandPE-conjugated streptavidinwere
used as secondary antibodies (BD Pharmingen, San Diego, CA). Follow-
ing staining, cells were resuspended in ice-cold FACS buffer, and data
were acquired on a FACSCanto flow cytometer (BD Biosciences) and
analyzed using DIVA software.
Statistical analysis. Results are expressed as means standard errors
of themeans (SEM). Group survival data were analyzed using a log rank p
test. All other data were analyzed with Student’s t test (two tailed) or the
nonparametric Mann Whitney U test. All statistical analyses were per-
formed using GraphPad Prism software, with a P value of0.05 consid-
ered to represent statistical significance.
RESULTS
Lectin profiling of carbohydrates onPECAM-1.Previous studies
have shown that high levels ofmannose sugars onCEACAM-1 can
be targeted by mannose-specific lectins such as type I fimbriae of
E. coli and S. Typhimurium (19). Based upon these findings,
we wanted to determine what carbohydrates are present on
PECAM-1. In order to define the carbohydrate residues present
on PECAM-1, a lectin profiling approach was used based upon
carbohydrate-lectin recognition: a series of biotin-labeled lectins
was used to capture immunoreceptor carbohydrate-lectin inter-
action using biotin-streptavidin and immunodetection of
PECAM-1with specific antibodies. The following biotin-labeled lec-
tins were tested: Aleuria aurantia lectin (AAL) [fucose (1,6)-N-
acetylglucosamine], concanavalin A (ConA) (-linked mannose),
Datura stramonium lectin (DSL) (	-1,4-linked acetylglucosamine),
Galanthus nivalis lectin (GNL) (-1,3-mannose), Griffonia sim-
plicifolia lectin (GSL) (-N-acetylgalactosamine -galactose), Ly-
copersicon esculentum lectin (LEL) (N-acetylglucosamine), Lotus
tetragonolobus lectin (LTL) (-linked fucose), Solanum tuberosum
lectin (STL) (N-acetylglucosamine), Sambucus nigra lectin (SNA)
(-2,6-linked sialic acid), Dolichos biflorus agglutinin (DBA)
(-linked N-acetylgalactosamine), and wheat germ agglutinin
(WGA) (N-acetylglucosamine). Figure 1 shows the lectin profiles
of cellular PECAM-1 (Fig. 1A), cellular CEACAM-1 (Fig. 1C), and
recombinant humanPECAM-1-Ig chimera (Fig. 1B). As shown in
FIG 1 PECAM-1 contains -linked mannose and N-acetylglucosamine sug-
ars as shown by lectin profiling. Biotinylated lectins (10 g) were added to
precleared 1.5-mg 15K Triton-soluble human platelet lysates and incubated at
4°C for 2 hwithmixing. A 50-l suspension of 50% streptavidin-agarose beads
was then added and incubated at 4°C for 1 h with constant mixing. Immuno-
precipitation products were washed and resuspended in SDS reducing buffer,
and proteins were separated by 10% SDS-PAGE and then transferred byWest-
ern blotting and probed with either a polyclonal anti-PECAM-1 antibody (A
and B) or an anti-CEACAM-1 antibody (C) using ECL as the substrate to
visualize bound antibody.
Lovelace et al.
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Fig. 1A, cellular PECAM-1 showed different degrees of binding
with the lectins ConA, WGA, LTL, STL, AAL, DSL, and LEL but
had no or little binding to protein G, GNL, GSL, SNA, or DBA. In
comparison, recombinant human PECAM-1-Ig chimera showed
a similar pattern of reactivity with protein G (via the Ig portion),
ConA, WGA, DSL, and LEL but did not bind LTL, STL, AAL,
GNL, SNA, and DBA (Fig. 1B). This is in contrast to the case for
cellular CEACAM-1, which showed a different carbohydrate pro-
file with various degrees of weak binding to ConA and WGA but
not LTL, STL, AAL, GNL, GSL, DSL, and LEL (Fig. 1C). A sum-
mary of the strengths of reactivity of various lectin interactions as
determined by band intensity in Western blotting with either cel-
lular PECAM-1, cellular CEACAM-1, or recombinant human
PECAM-1-Ig chimera protein is shown in Table 1. These data
indicate that PECAM-1 and CEACAM-1 both have -linked
mannose sugars andN-acetylglucosamine sugars, with no binding
affinity to N-acetylgalactosamine or sialic acid sugars, indicating
that neither has these carbohydrate modifications.
Human PECAM-1 and murine PECAM-1 bind S. Typhimu-
rium in vitro. Previous studies have shown that high levels of
mannose sugars on CEACAM-1 can be targeted by mannose-spe-
cific microbial lectins such as type 1 fimbriae of E. coli and S.
Typhimurium (19). These original studies on CEACAM-1 and
bacterial pathogens were restricted to humans, as mouse
CEACAM-1 does not recognize many of the identified bacterial
pathogens, including S.Typhimurium.Based upon these findings,
it was important to determine whether human PECAM-1 and
mouse PECAM-1 bind to Gram-negative bacteria, including S.
Typhimurium, before embarking on mouse models of S. Typhi-
murium infection in vivo. In order to address this issue, a whole-
cell Salmonella ELISA was performed to study the interaction of
human and murine PECAM-1-Ig chimera and S. Typhimurium
SL1344 in vitro. Bovine serum albumin (BSA)-coated plates were
used as a negative control, as BSA lacks any high-mannose-type
carbohydrate chains (Fig. 2).
As shown in Fig. 2A, bound bacteria were detected on plates
coated with human PECAM-1-Ig chimera using rabbit anti-Sal-
monella antibody. The binding reached a plateau at an optical
density (OD) at 405 nm of 1.25 when the protein concentration
was 2.0 g/ml. Little or no binding of S. Typhimurium was ob-
served when BSA-coated plates were used as negative controls or
when normalmouse serumwas used instead of rabbit anti-Salmo-
nella antibodies. There was a 3-fold increase in S. Typhimurium
binding to PECAM-1-Ig chimera compared to binding to BSA.
Similarly, S. Typhimurium bacteria bound to murine PECAM-
1-Ig chimera, and this binding was quantified with a rabbit anti-
Salmonella antibody. The binding reached a plateau at an OD at
405 nm of 1.05 when the protein concentration was 2.0 g/ml,
and there was an approximately 2-fold increase in binding com-
pared to that with the negative-control antigen, BSA. No binding
was observed when normal rabbit serum was used (Fig. 2B).
Taken together, these results demonstrate that both human and
murine PECAM-1-Ig chimera can bind S. Typhimurium in vitro
in a dose-dependent, saturable manner.
Increased resistance of PECAM-1/ mice to oral infection
with S. Typhimurium SL1344. Considering that PECAM-1 is
expressed by epithelial cells and macrophages, which are known
host cells for S. Typhimurium, and having demonstrated that
PECAM-1 contains lectin-binding sites that specifically interact
with bacterial structures, including S. Typhimurium, we next in-
vestigated the effect of absence of PECAM-1 in S. Typhimurium
infection (25, 26). Mice were orally infected with various doses of
virulent S. Typhimurium SL1344 (105 CFU, 104 CFU, and 103
CFU). Mice were observed for symptoms of salmonellosis for 7 to
10 days and were euthanized when humane endpoints were
reached. Fig. 3A and B show that at higher infectious doses (105
and 104 CFU, respectively) there was little difference in the sus-
ceptibilities of PECAM-1/ and wild-type C57BL/6 mice, but at
a lower infectious dose of 103 CFU, PECAM-1/ mice were
clearly more resistant to infection (80% survival) than wild-type
C57BL/6 mice (Fig. 3C). Subsequent experiments to further in-
vestigate the increased resistance to S. Typhimurium infection by
PECAM-1/ mice were therefore performed with an infectious
dose of 103 CFU SL1344.
As S. Typhimurium infection is normally acquired through
ingestion of contaminated water or food, we employed a natural
oral-fecal transmission model as well as the oral infection model
to further explore the susceptibility of PECAM-1/ mice to in-
fection with S. Typhimurium (24). To facilitate transmission of S.
Typhimurium from infected to uninfected mice, naive mice were
TABLE 1 Reactivities of cellular PECAM-1 and CEACAM-1 and PECAM-1-Ig chimera with biotinylated lectins of different sugar specificities
Biotinylated lectina Specificity
Activityb
Cellular PECAM-1 PECAM-1-Ig chimera Cellular CEACAM1
AAL Fucose(1,6)-N-acetylglucosamine   
DSL 	-1,4-Linked N-acetylglucosamine   
GNL -1,3-Mannose   
GSL -N-Acetyl galactosamine -galactose   
LEL N-Acetylglucosamine   
LTL -Linked fucose   
STL N-Acetylglucosamine   
SNA -2,6-Linked sialic acid   
DBA -Linked N-acetylgalactosamine   
ConA -Linked mannose   
WGA N-Acetylglucosamine   
Protein G Binds via Ig portion   
a AAL, Aleuria aurantia lectin; DSL, Datura stramonium lectin; GNL, Galanthus nivalis lectin; GSL, Griffonia simplicifolia lectin; LEL, Lycopersicon esculentum lectin; LTL, Lotus
tetragonolobus lectin; STL, Solanum tumerosum lectin; SNA, Sambucus nigra agglutinin; DBA, Dolichos biflorus agglutinin; ConA, concanavalin A; WGA, wheat germ agglutinin.
b, no reactivity; weak to strong reactivity is graded to.
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cohoused with orally infected (106 CFU) mice. Transmission was
monitored by measuring the number of Salmonella bacteria in
fecal pellets, and the onset of salmonellosis was monitored by
observation for clinical signs. Figure 3D demonstrates that naive
PECAM-1/ mice showed 100% survival when cohoused with
infected animals, while 75% of cohoused naive C57BL/6 mice be-
came infected and moribund. To further demonstrate reduced
susceptibility of PECAM-1/ mice to oral infection with S. Ty-
phimurium, the experiment was repeated with larger groups of
mice (n
 15), which were all infected with 103 CFU S. Typhimu-
rium SL1344 by oral gavage and monitored for onset of disease.
Figure 3E shows that PECAM-1/mice were significantly more
resistant to infection (P  0.005, log rank p test) than wild-type
C57BL/6 mice, confirming our observations with the natural
transmission infection model.
Resistance of PECAM-1/ mice to infection with S. Typhi-
murium was further characterized by enumeration of bacterial
burdens in organs of infectedmice.Mice were orally infected with
103 CFU SL1344, and at 5 days after infection, the bacterial loads
in liver, spleen, mesenteric lymph nodes (MLN), and brain were
determined by viable counts in tissue homogenates. In addition,
the bacterial load in freshly collected fecal pellets was determined
by viable count. Figure 4A shows that at early time points after
infection, no difference in the number of SL1344 bacteria shed in
feces was detected betweenC57BL/6 and PECAM-1/mice, sug-
gesting that in the gastrointestinal tract, the bacterial load was
comparable between mouse strains. At 5 days after oral infection,
the bacterial load in PECAM-1/ mice was significantly (P 
0.05, n 
 14) lower in all systemic organs tested than that in
C57BL/6 mice (Fig. 4B). Taken together, these data imply that
dissemination of S. Typhimurium from the gastrointestinal tract
into deeper tissues is delayed in mice lacking PECAM-1.
Proinflammatory cytokine responses are altered in PECAM-
1/ mice during S. Typhimurium SL1344 infection. Previous
studies have shown that the production of cytokines and soluble
factors by macrophages is important during the early phases of S.
Typhimurium infection (25). These earlier studies showed that
macrophage-derived cytokines such as IL-6, TNF-, and IFN-
are typically enhanced during S. Typhimurium infection (27). As
PECAM-1 is expressed onmacrophages and these cells serve as the
major host cell, we next investigated whether the resistance to S.
Typhimurium infection in PECAM-1/ mice was associated
with altered circulating levels of these cytokines during infection.
Mice were infected orally with 103 CFU S. Typhimurium SL1344,
and bloodwas taken from themice at 5 days after oral infection for
cytokine analyses. As shown in Fig. 5A to F, PECAM-1/ mice
produced significantly lower levels of proinflammatory cytokines
IFN- (P 0.01, n
 11), MCP-1 (P 0.001, n
 11), IL-6 (P
0.05, n
 11), and TNF- (P 0.05, n
 11) than did wild-type
C57BL/6 mice, whereas no difference in the levels of IL-12p70
(P  0.05, n 
 11) and anti-inflammatory cytokine IL-10 (P 
0.05, n 
 11) (using nonparametric Mann Whitney U test) was
observed. Importantly, no significant differences were found in
any of the cytokine levels between uninfected PECAM-1/ and
uninfected wild-type C57BL/6 mice (Fig. 5).
PECAM-1/ peritoneal macrophages release reduced
amounts of proinflammatory cytokines following stimulation
with live or heat-killed S. Typhimurium or with TLR ligands in
vitro. Next, we compared cytokine production by cultured resi-
dent peritoneal macrophages from PECAM-1/mice and wild-
type C57BL/6 mice in response to Salmonella infection. Initially,
we confirmed the expression of PECAM-1 and TLR4 on the sur-
face of resident peritoneal macrophages and intracellular expres-
sion of TLR3 using flow cytometry. As shown in Fig. 6A, the purity
of the peritoneal macrophages was confirmed using the F4/80
macrophage marker, and no difference between wild-type
C57BL/6 and PECAM-1/ macrophages was detected. The F4/
80-positive macrophages from both strains of mice expressed
equivalent levels of TLR4 (Fig. 6C) and TLR3 (Fig. 6D), while
PECAM-1 was detected at modest levels on F4/80 cells from
C57BL/6mice andwas absent on cells fromPECAM-1/ animals
(Fig. 6B).
To test the hypothesis that PECAM-1/ peritoneal macro-
phages may have altered inflammatory responses to S. Typhimu-
rium infection, we examined cytokine levels released by peritoneal
macrophages upon exposure to live and heat-killed S. Typhimu-
FIG 2 Dose response of binding of PECAM-1-Ig chimera to S. Typhimurium
determined by ELISA. Binding of human PECAM-1-Ig chimera (0 to 2.0 g/
ml) (A) or murine PECAM-1-Ig chimera (B) and bovine serum albumin (0 to
2.0 g/ml) to S. Typhimurium was visualized using an ELISA-based assay, in
which microtiter plates coated with the indicated amounts of PECAM-1-Ig or
BSA were used and binding of S. Typhimurium to the chimeric proteins was
visualized using rabbit anti-Salmonella antibody and anti-rabbit alkaline phos-
phatase-conjugated antibody.
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rium SL1344 in vitro (Fig. 7). Supernatants were collected 24 h
after exposure to Salmonella and then analyzed using the CBA
mouse inflammation kit. Stimulated macrophages produced
both IL-6 and TNF-, and the amount of cytokines produced
increased with increasing multiplicity of infection (MOI)
(Fig. 7). In comparison with C57BL/6 macrophages, PECAM-
1/ macrophages infected with live or heat-killed S. Typhi-
murium SL1344 produced reduced levels of IL-6 and TNF-
(P  0.05, n 
 3) (Fig. 7).
One of the major pathways leading to production of pro- and
anti-inflammatory cytokines by macrophages is following ac-
tivation of Toll-like receptors (TLRs) by their respective li-
gands. Consequently, it was important to investigate whether
any specific TLR was affected by deficiency of PECAM-1 in
macrophages. For these experiments, peritoneal macrophages
were harvested from wild-type C57BL/6 and PECAM-1/
mice, cultured for 2 days as described above, and then treated
with either the TLR2 agonist peptidoglycan (PGN), the TLR4
agonist Salmonella lipopolysaccharide (LPS), the TLR7 agonist
Loxoribine (LXR), the TLR9 agonist CpG oligonucleotide, or
the TLR3 agonist poly(I·C) for 8 h before supernatants were
removed for cytokine analysis.
The results in Fig. 8 demonstrate that a lack of PECAM-1 ex-
pression on macrophages affected cytokine production in a TLR
ligand-dependent manner. Following stimulation with LPS, pro-
duction of IL-6, TNF-, and MCP-1 was significantly P 0.001)
reduced in PECAM-1/ macrophages compared to C57BL/6
macrophages. Similarly, stimulation of PECAM-1/ macro-
phages with poly(I·C) also showed significantly (P  0.05) re-
duced TNF- and MCP-1 levels compared to that of wild-type
C57BL/6 macrophages (Fig. 8B). In contrast, stimulation of
C57BL/6 and PECAM-1/macrophages with PGN showed high
IL-6, TNF-, and MCP-1 responses; however, there were no signif-
icant difference between the two genotypes. In addition, cytokine
release following stimulation with CpG or LXR was no different be-
tween cultures of C57BL/6 and PECAM-1/ macrophages (P 
0.05, n
 3) (Fig. 8). The differences in cytokine responses were not
due to altered cell viability (Fig. 8D). These results suggest a possible
FIG 3 Absence of PECAM-1 increases resistance to S. Typhimurium SL1344 infection in vivo. (A to C) Groups of five naive C57BL/6 WT () or
PECAM-1/ (o) mice were infected with either 105 CFU (A), 104 CFU (B), or 103 CFU (C) virulent S. Typhimurium SL1344 by oral gavage. For ethical
reasons, mice were culled when they becamemoribund; these mice were deemed “nonsurvivors.” (D) One wild-type C57BL/6mouse was orally inoculated
with 106 CFU S. Typhimurium SL1344 and cohoused with four naive C57BL/6 mice or four PECAM-1/ mice. The course of infection of all mice was
followed by measuring survival over time. The experiment was performed with two cages for each mouse treatment, and the data are represented as
means SEM. (E) Age- and sex-matched mice, C57BL/6 () and PECAM-1/ (o) mice (n
 15) were infected orally with 103 CFU of S. Typhimurium
SL1344, and their survival was monitored for 12 days. The y axis indicates survival, and the x axis indicates days after infection. For ethical reasons, mice
were culled when moribund.
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relationship between PECAM-1 andTLR3 andTLR4 signaling path-
ways involving cytokine release.
DISCUSSION
Recent evidence suggests that the Ig-ITIM-bearing receptor
CEACAM-1 serves as a receptor for bacterial pathogens, including
S. Typhimurium, E. coli, N. gonorrhoeae, and N. meningitidis in
humans (18). CEACAM-specific adhesins allow bacterial or viral
pathogens to attach to, invade, and/or transcytose polarized epi-
thelia and endothelia to colonize host tissues. Whether this is the
case for closely related immunoreceptors such as PECAM-1 is
unknown. Studies on CEACAM-1 and bacterial pathogens have
been restricted to humans, as mouse CEACAM-1 does not recog-
nize many of the identified bacterial pathogens, including S. Ty-
FIG 4 Reduced bacterial loads in PECAM-1/ mice compared to C57BL/6
mice following oral S. Typhimurium SL1344 infection. C57BL/6 (PECAM-
1/) (black symbols) and PECAM-1/ (white symbols) mice were inocu-
lated orally with 103 CFU S. Typhimurium SL1344. (A) At the indicated time
points after infection, fresh fecal pellets were collected and bacterial load was
determined by viable count. Results were obtained in 2 independently per-
formed experiments. Shown are results from individual mice (symbols); the
horizontal bar indicates the geometric mean of each group. (B) At 5 days after
infection, mice were euthanized, and bacterial loads in liver, spleen,MLN, and
brain were determined by viable count. Results were obtained in 3 indepen-
dently performed experiments. Shown are results from individual mice (sym-
bols) (n
 14 for each organ); the horizontal bar indicates the geometric mean
of each group. Data were analyzed using a nonparametric Mann-Whitney U
test. *, P 0.05; **, P 0.01.
FIG 5 PECAM-1/ mice have reduced serum proinflammatory cytokine
responses following S. Typhimurium SL1344 infection in vivo. Wild-type
C57BL/6 and PECAM-1/ mice were infected orally with 1  103 CFU S.
Typhimurium SL1344 or left uninfected. Both cohorts were sacrificed on day 5
after infection. Blood samples were collected via cardiac puncture, and serum
was separated for cytokine analysis. The following cytokines were analyzed
using amouseCBA inflammation kit: IFN- (A),MCP-1 (B), IL-6 (C), TNF-
(D), IL-12-p70 (E), and IL-10 (F). Data were collected from a total of three
independent experiments (n 
 11 infected mice of each strain and n 
 6
uninfected mice of each strain). Data were analyzed using a nonparametric
Mann-Whitney U test. *, P 0.05.
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phimurium. Therefore, it was important to define whether mu-
rine PECAM-1 binds to S. Typhimurium in vitro before
embarking upon in vivomouse models of systemic infection. Our
results show that PECAM-1, like CEACAM-1, contains N-acetyl-
glucosamine and -linked mannose sugars as determined by lec-
tin profiling (Fig. 1 and Table 1). We showed that cellular
PECAM-1derived fromprimary cells (platelets or leukocytes) and
CHO-K1-derived recombinant human PECAM-1 Ig chimera
bound specifically toN-acetylglucosamine and-mannose sugars
(ConA) (GlcNAcMan) but not other lectins (fucose, GalNAc,
and mannan) (Table 1). As N-acetylglucosamine is a major com-
ponent of peptidoglycan, it is likely that PECAM-1 binds Gram-
positive bacteria (such as staphylococci, streptococci, Listeria, and
Bacillus) that are known to be associated with infectious diseases
in humans. In addition, the -mannose sugars will target binding
of type I fimbrial lectins of E. coli and S.Typhimurium, suggesting
that PECAM-1, like CEACAM-1, may also bind some Gram-neg-
ative organisms. Indeed, we demonstrated thatmouse and human
PECAM-1 Ig chimeric proteins were able to bind S.Typhimurium
in vitro.
Having confirmed thatmouse PECAM-1 binds to S.Typhimu-
rium SL1344, we used virulent S. Typhimurium SL1344 in a
mouse model of salmonellosis to determine the role of PECAM-1
in resistance to Salmonella infection. We show that PECAM-1/
mice are more resistant to oral S. Typhimurium infection than
wild-type (WT) C57BL/6 mice, as evidenced by reduced morbid-
ity and mortality (Fig. 3) and lower bacterial loads in systemic
organs, including spleen, liver, MLN, and brain (Fig. 4), following
oral infection with low doses. Interestingly, our data showed that
at early time points after infection, the bacterial loads in the gas-
trointestinal tissues, determined by viable count in fecal pellets,
are comparable in C57BL/6 and PECAM-1-deficient mice, sug-
gesting that the reduced susceptibility of PECAM-1-deficientmice
to oral infection with S. Typhimurium is due to reduced extraint-
estinal dissemination of the infection from the gut to the systemic
organs. Additional experiments using systemic infection routes
are warranted to further address whether this diminished spread
explains why PECAM-1-deficient mice are less susceptible to S.
Typhimurium infection. However, others have shown that fol-
lowing intraperitoneal infection with an attenuated strain of S.
Typhimurium, PECAM-1 deficiency results in delayed clearance
of Salmonella infection as a result of impaired T-cell responses
(28). However, the initial establishment of infection and bacterial
loads during the early-phase response, which is known to be T-cell
independent, were not altered (29). Thus, these data would sug-
gest that following systemic infection, initial establishment of in-
fection and spread within the reticulo-endothelial system (RES)
would be comparable in PECAM-1-deficient and wild-type mice.
Therefore, these data imply that PECAM-1 deficiencymight affect
susceptibility to Salmonella infection due to reduced extraintesti-
nal dissemination but that once the bacteria reach systemic or-
gans, the lack of PECAM-1 does not affect further spread of the
infection.
S. Typhimurium is an invasive enteric pathogen that preferen-
tially breaches the epithelial barrier by targeting M cells in Peyer’s
patches but can also invade epithelial cells or be directly taken up
from the lumen by CD18 phagocytic dendritic cells (30–33).
PECAM-1 is unlikely to play a role in S. Typhimurium entry into
M cells, as previous studies have shown an absence of PECAM-1
expression on in vitro cultured M-cell-like cells (25). However,
PECAM-1 is expressed on the surfaces of macrophages and den-
dritic cells and thus may be important in interaction with these
host cells (15, 34). Uptake of S. Typhimurium is enhanced by
opsonization with antibodies through Fc receptor-mediated
phagocytosis, but it is thought that other receptors on host cells
also play a role in internalization. As we have shown that
PECAM-1 can bind to Salmonella adhesins, it would be interesting
to further explore the role of PECAM-1 in Salmonella uptake by
macrophages and dendritic cells. In this context, it is noteworthy
that Ross et al. found that at least in in vitro experiments, adherent
splenic cells from wild-type and PECAM-1/mice infected with
S. Typhimurium contain comparable numbers of intracellular
bacteria (28). Indeed, while PECAM-1may play a role in uptake of
Salmonella by phagocytic cells, there are likely other receptors in-
volved.
While macrophages are used as an intracellular niche for rep-
lication, S. Typhimurium does not replicate in dendritic cells. In-
stead, the Salmonellabacteria interferewith the induction of adap-
tive immune responses and with the trafficking of dendritic cells
to draining lymph nodes and the bloodstream. Residing sheltered
from immune attack inside dendritic cells, S. Typhimurium ex-
ploits the migrating properties of dendritic cells to reach into
FIG 6 PECAM-1, F4/80, TLR3, and TLR4 expression bymacrophages derived
fromwild-typeC57BL/6 andPECAM-1/mice. (A) Flow cytometric analysis
of F4/80 surface expression on murine macrophages. Macrophages were
stained with PE-conjugated monoclonal antibody (MAb) F4/80. (B) Flow cy-
tometric analysis of PECAM-1 surface expression on murine macrophages.
Macrophages were stained with anti-PECAM-1 antibody followed by a sec-
ondary FITC-conjugated anti-rat antibody. (C) Flow cytometric analysis of
TLR4 surface expression on murine macrophages. Macrophages were stained
with PE-conjugated anti-TLR4 antibody. (D) Flow cytometric analysis of in-
tracellular TLR3 expression on murine macrophages. Macrophages were
stained with FITC-conjugated anti-TLR3 antibody. All results are representa-
tive of three independent experiments. In each panel, the dotted line represents
the isotype control antibody.
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deeper tissues and organs (35). Interestingly, our data showed
reduced dissemination of Salmonella from the gastrointestinal
tract into systemic organs in the absence of PECAM-1. PECAM-1
was shown to be essential for human dendritic cell migration
through the lymphatics, and it is thus likely that PECAM-1 is
involved in dendritic cell trafficking (34). No differences in the
number of CD11c cells in the spleens of naive and infected
PECAM-1/mice in comparison with wild-typemice have been
reported, and the antigen-presenting capacities of cultured den-
dritic cells of PECAM-1/ and wild-type mice are comparable
(28). However, the functional abilities of dendritic cells in
PECAM-1-deficient mice and particular dendritic cell popula-
tions in the gastrointestinal lymphoid tissue have not been stud-
ied. Thus, while outside the scope of this study, investigations into
the migratory capacity of dendritic cells in Salmonella-infected
PECAM-1/mice and thorough analysis of uptake of S. Typhi-
murium by gastrointestinal dendritic cells are warranted to clarify
whether the reduced extraintestinal dissemination of Salmonella
in PECAM-1-deficient mice could be due to reduced uptake by
dendritic cells and/or diminished migration of dendritic cells.
Various biological roles for PECAM-1 in thrombosis, inflam-
mation, and the immune system have been identified (35). The
role of PECAM-1 in the inflammatory process seems to depend on
the stimulus and tissues involved and the genetic background
whenmurine studies are concerned (reviewed in references 35, 36
and 37). The role of PECAM-1 in leukocyte extravasation, an es-
sential process in inflammation, is well established. However,
C57BL/6 mice (which were used in this study) have normal leu-
kocyte migration responses when interactions with PECAM-1 are
blocked (38), and thus any effects of the absence of PECAM-1 are
likely due to role of PECAM-1 inmaintaining vascular integrity or
in regulation of inflammatory cytokine production. The role of
PECAM-1 protein in inflammation has been explored in several
models of inflammatory disease, including collagen-induced ar-
thritis, experimental autoimmune encephalitis, croton oil-in-
duced dermatitis, and endotoxic shock (35, 36), and these studies
have alluded to complex pro- and anti-inflammatory roles for
PECAM-1. In the C57BL/6 background, many of these studies
suggest an anti-inflammatory role for PECAM-1, attributed
mostly to modulation of cytokine production and/or changes in
vasculature. However, the role of PECAM-1 in mediating aspects
of the inflammatory process may be stimulus dependent and in-
fluenced by the cytokine milieu. For instance, leukocyte emigra-
tion is dependent on PECAM-1 expression following exposure to
IL-1	 but not in the presence of TNF-. Thus, further investiga-
tions are needed to completely understand the complexity of these
interactions.
Observations in PECAM-1-deficient mice in a model of endo-
toxic shock are seemingly in contrast to our observations during
Salmonella infection. Inducing endotoxic shock by injecting
lipopolysaccharide (LPS) (13), Maas et al. demonstrated that
PECAM-1/mice had a higher mortality rate following LPS ex-
posure than wild-type mice, due to lack of PECAM-1 expression
in the vasculature, so that loss of PECAM-1 expression at endo-
thelial cell-cell junctions resulted in increased vascular permeabil-
ity, increased fluid loss, and failure to recover from hypotension.
The discrepancy between the study by Maas et al. and the study
presented here could be explained by the different disease models
used, as oral infection with S. Typhimurium is not likely to result
in endotoxic shock from high levels of soluble LPS. Rather, S.
Typhimurium is known to reside intracellularly during infection,
preferably in macrophages of the RES (39). In addition, in our
FIG 7 Live and heat-killed S. Typhimurium SL1344-infected cultured PECAM-1/ macrophages display reduced IL-6 (A and C) and TNF- (B and D)
cytokine levels at all bacterium/cell ratios tested (1:1, 5:1, and 10:1) compared to wild-type C57BL/6 macrophages. Peritoneal macrophages were obtained from
wild-type C57BL/6 and PECAM-1/mice and cultured in the presence of 10% (vol/vol) FCS and L-cell conditionedmedium for 2 days. Cells were seeded and
either left untreated or infected with S. Typhimurium SL1344 (live or heat killed) at different bacterium/cell ratios. Following 1 h of infection, bacteria were
removed bywashing and treatmentwith 300l of 50g/ml gentamicin for 40min at 37°C and then 24 h of incubation, and supernatantswere collected. Cytokine
analysis was performed using the mouse CBA inflammation kit, with detection on a FACSCanto flow cytometer. Three independent experiments were
performed, with each treatment being performed in triplicate. Data are presented as means SEM.
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study the increased resistance of PECAM-1/ mice to infection
was especially evident with low doses of S. Typhimurium, which
are more reflective of naturally acquired infections (24) and
should not result in high levels of circulating, soluble LPS.
The results of this study demonstrated that increased resistance
to Salmonella infection correlated with reduced levels of circulat-
ing cytokines. However, it is well known that early control of Sal-
monella infections is dependent on innate immune responses and
that the production of inflammatory cytokines such as TNF- is
essential for control of infection (27, 40–42). The reduced cyto-
kine levels in PECAM-1/ mice can therefore not explain the
relative increase in resistance. Instead, we suggest that the reduced
cytokine levels are reflective of the lower bacterial load detected in
these animals. It would be interesting to further explore the cyto-
kine production on a tissue-specific level, i.e., in the gastrointes-
tinal tract (comparable bacterial loads) compared with the spleen
or liver (increased bacterial load in PECAM-1-deficient animals)
to better understand the complexity of local, tissue-specific pro-
inflammatory cytokine production in response to bacterial infec-
tion. However, we further explored the production of inflamma-
tory cytokines by peritoneal macrophages in in vitro experiments
in which the macrophages from each mouse strain were exposed
to similar bacterial loads or TLR ligands. The outcome of these
experiments highlighted an interesting difference between re-
sponses from PECAM-1-deficient macrophages and wild-type
macrophages, namely, that macrophages from PECAM-1-defi-
cient mice produced reduced levels of TNF-, IL-6, IFN-, and
MCP in response to culture with S. Typhimurium. Further, we
demonstrate that following stimulation with LPS (TLR4 ligand)
or to a lesser extent poly(I·C) (TLR3 ligand), but not other TLR
ligands, production of inflammatory cytokines (TNF- and IL-6)
by PECAM-1-deficient macrophages was reduced (43).
The signaling pathways leading to pro- or anti-inflammatory
pathways may be regulated differently in various cell types, and
therefore ligation of PECAM-1 on different cells may result in
different outcomes. In this study, we did not further investigate
the activation of signaling pathways in PECAM-1/ macro-
phages following exposure to S. Typhimurium, LPS, or poly(I·C).
Other studies have shown that PECAM-1 plays an anti-inflamma-
tory role by dampening cytokine production through ITIM/
SHP-2 interactions. Studies by Rui et al. have shown that in T
lymphocytes, ligation of PECAM-1 can result in interference with
IRF-3, NF-B, and JNK pathways (16). Other studies have dem-
onstrated that in endothelial cells, ligation of PECAM-1may pro-
long STAT3 activation, as the scavenging of SHP-2 by PECAM-1
ITIM prevents the dephosphorylation of STAT3. The molecular
FIG 8 TLR ligand stimulation of cultured PECAM-1/ macrophages revealed reduced inflammatory cytokine release compared to that with wild-type
C57BL/6 macrophages. Resident peritoneal macrophages were obtained from wild-type C57BL/6 and PECAM-1/mice and cultured in the presence of 10%
(vol/vol) FCS and 50% L-cell conditionedmedium for 2 days. For experiments, the mediumwas changed and cells were seeded in 0.5% (vol/vol) FCS and either
left untreated or stimulated with various TLR ligands [LPS, poly(I·C), PGN, CpG, or LXR) at the indicated concentrations. Following 1 h of exposure to the
various ligands followed by a 24-h incubation, supernatants were collected. Cytokine analysis was performed using the mouse CBA inflammation kit, and
detection was with a FACSCanto flow cytometer. Data are presented for the IL-6 (A), TNF- (B), andMCP-1 (C) cytokines. A trypan blue cell viability assay was
also performed (D). Three independent experiments were performed with each treatment in triplicate cultures, and data are presented as means SEM.
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mechanism by which S. Typhimurium-mediated ligation of
PECAM-1 or LPS-mediated stimulation of TLR4 results in re-
duced production of inflammatory cytokines remains unknown
and is worthy of further investigation.
In summary, our results indicate that PECAM-1 plays a role in
modulating the innate immune response during S. Typhimurium
pathogenesis both in vivo and in vitro. This study demonstrates
that PECAM-1 plays a role in recognition and binding of S. Ty-
phimurium, in resistance to extraintestinal dissemination of S.
Typhimurium following oral infection in vivo, and inmacrophage
inflammatory responses in vitro. Further understanding of the
mechanisms by which PECAM-1 regulates/interferes with Salmo-
nella infectionsmay open up opportunities to develop therapeutic
approaches based on blockade of PECAM-1 ligation and signal-
ing.
ACKNOWLEDGMENTS
This work was supported by grants from theNational Health andMedical
Research Council of Australia (603812) (to D.E.J.). M.D.L. is supported
by a Rebecca Cooper Foundation grant. M.L.Y. is a postgraduate student
of the University ofMelbourne. D.E.J. is a recipient of an NHMRC Senior
Research Fellowship. O.W. is a recipient of an NHMRC Career Develop-
ment Fellowship.
REFERENCES
1. Lanoue A, Clatworthy MR, Smith P, Green S, Townsend MJ, Jolin HE,
Smith KG, Fallon PG, McKenzie AN. 2004. SIGN-R1 contributes to
protection against lethal pneumococcal infection in mice. J. Clin. Invest.
200:1383–1393.
2. Cossart P, Sansonetti PJ. 2004. Bacterial invasion: the paradigms of
enteroinvasion pathogens. Science 304:242–248.
3. Wijburg OL, Simmons CP, van Rooijen N, Strugnell RA. 2000. Dual
role for macrophages in vivo in pathogenesis and control of murine Sal-
monella enterica var. Typhimurium infections. Eur. J. Immunol. 30(3):
944–953.
4. Wilkinson R, Lyons AB, Roberts D, Wong MX, Bartley PA, Jackson DE.
2002. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31)
acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-
mediated activation, and autoimmune disease. Blood 100:184–193.
5. Jones KL, Hughan SC, Dopheide SM, Farndale RW, Jackson SP, Jack-
son DE. 2001. Platelet endothelial cell adhesion molecule-1 is a negative
regulator of platelet-collagen interactions. Blood 98:1456–1463.
6. Patil S, Newman DK, Newman PJ. 2001. Platelet endothelial cell adhe-
sion molecule-1 serves as an inhibitory receptor that modulates platelet
responses to collagen. Blood 97:1727–1732.
7. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S,
Ruddle NH, Engelhardt B, Madri JA. 2002. Altered vascular permeability
and early onset of experimental autoimmune encephalomyelitis in
PECAM-1-deficient mice. J. Clin. Invest. 109:383–392.
8. Muller WA,Weigl SA, Deng X, Phillips DM. 1993. PECAM-1 is required
for transendothelial migration of leukocytes. J. Exp. Med. 178:449–460.
9. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR,
Jones ML, Ward PA, Albelda SM. 1993. Involvement of platelet-
endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo.
Science 262:1580–1582.
10. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. 1994. Monoclonal
antibody tomurine PECAM-1 (CD31) blocks acute inflammation in vivo.
J. Exp. Med. 179:1059–1064.
11. WongMX, Roberts D, Bartley PA, Jackson DE. 2002. Absence of platelet
endothelial cell adhesionmolecule-1 (CD31) leads to increased severity of
local and systemic IgE-mediated anaphylaxis and modulation of mast cell
activation. J. Immunol. 168:6455–6462.
12. Gao Sun W, Christofidou-Solomidou M, Sawada M, Newman DK,
Bergom C, Albelda SM, Matsuyama S, Newman PJ. 2003. PECAM-1
functions as a specific and potent inhibitor of mitochondrial-dependent
apoptosis. Blood 102:169–179.
13. Maas M, Stapleton M, Bergom C, Mattson DL, Newman DK, Newman
PJ. 2005. Endothelial cell PECAM-1 confers protection against endotoxic
shock. Am. J. Physiol. Heart. Circ. Physiol. 288:H159–164.
14. Carrithers M, Tandon S, Canosa S, Michaeud M, Graesser D, Madri JA.
2005. Enhanced susceptibility to endotoxic shock and impaired STAT
signalling in CD31-deficient mice. Am. J. Pathol. 166:185–196.
15. Wang J, Wu Y, Wang W, Lu Y, Mao H, Liu X, Liu Z, Chen BG. 2011.
Syk protein tyrosine kinase involves PECAM-1 signaling through tandem
immunoreceptor inhibitory motifs in human THP-1 macrophages. Cell.
Immunol. 272:39–44.
16. Rui Y, Liu X, Li N, Jiang Y, Chen G, Cao X, Wang J. 2007. PECAM-1
ligation negatively regulates TLR4 signaling in macrophages. J. Immunol.
179:7344–7351.
17. Lund FE, Randall TD, Partida-Sanchez S. 2005. Regulation of immune
responses by CD38 and cADPR, p 217–240. In Lee HC (ed), Cyclic ADP-
ribose and NAADP: structures, metabolism and functions. Kluwer, Dor-
drecht, Netherlands.
18. Gray-Owens SD, Blumberg RS. 2006. CEACAM1: contact-dependent
control of immunity. Nat. Immunol. 6:433–446.
19. Horst AK, Wagener C. 2004. CEA-related CAMs. Handb. Exp. Pharma-
col. 165:283–314.
20. Villullas S, Hill DJ, Sessions RB, Rea J, Virji M. 2007. Mutational
analysis of human CEACAM1: the potential of receptor polymorphism in
increasing host susceptibility to bacterial infection. Cell. Microbiol.
9:329–346.
21. Duncan GS, Andrew DP, Takimoto H, Kaufman SA, Yoshida H, Spell-
berg J, Luis de la Pompe J, Elia A, Wakeham A, Karan-Tamir B, Muller
WA, Senaldi G, Zukowski MM, Mak TW. 1999. Genetic evidence for
functional redundancy of platelet/endothelial cell adhesion molecule-1
(PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PE-
CAM-1-independent functions. J. Immunol. 162:3022–3030.
22. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D,
Skamene E, Olivier M, Jothy S, Gros P. 1995. The Ity/Lsh/Bdg locus:
natural resistance to infection with intracellular parasites is abrogated by
disruption of the Nramp1 gene. J. Exp. Med. 182:655–666.
23. Uren TK, Wijburg OL, Simmons C, Johansen FE, Brand T, Zaeg P,
Strugnell RA. 2005. Vaccine-induced protection against gastrointestinal
bacterial infections in the absence of secretory antibodies. Eur. J. Immu-
nol. 35:180–188.
24. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P,
Strugnell RA. 2006. Innate secretory antibodies protect against natural
Salmonella typhimurium infection. J. Exp. Med. 203:21–26.
25. Baranov V, Hammarstrom S. 2004. Carcinoembryonic antigen (CEA)
and CEA-related cell adhesion molecule 1 (CEACAM1), apically ex-
pressed on human colonic M cells, are potential receptors for microbial
adhesion. Histochem. Cell Biol. 121:83–89.
26. Huang GT, Eckmann L, Savidge TC, Kagnoff MF. 1996. Infection of
human intestinal epithelial cells with invasive bacteria upregulates apical
intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil
adhesion. J. Clin. Invest. 98:572–583.
27. Eckmann L, Kagnoff MF. 2001. Cytokines in host defense against Salmo-
nella. Microbes Infect. 3:1191–1200.
28. Ross EA, Coughlan RE, Flores-Langarica Bobat AS, Marshall JL, Hus-
sain K, Charlesworth J, Abhyankar N, Hitchcock J, Gil C, Lopez-Macias
C, Henderson IR, Khan M, Watson SP, MacLennan ICM, Buckley CD,
Cunningham AF. 2011. CD31 is required on CD4 T cells to promote T
cell survival during Salmonella infection. J. Immunol. 187:1553–1565.
29. Hess J, Ladel C, Miko D, Kaufmann SH. 1996. Salmonella typhimurium
aroA infection in gene-targeted immunodeficient mice: major role of
CD4 TCR-alpha beta cells and IFN-gamma in bacterial clearance inde-
pendent of intracellular location. J. Immunol. 156:3321–3326.
30. Arques JL, Hautefort I, Ivory K, Bertelli E, Regoli M, Clare S, Hinton
JC, Nicoletti C. 2009. Salmonella induces flagellin- and MyD88-
dependent migration of bacteria-capturing dendritic cells into the gut
lumen. Gastroenterology 137:579–587.
31. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R,
Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P. 2001. Dendritic
cells express tight junction proteins and penetrate gut epithelial monolay-
ers to sample bacteria. Nat. Immunol. 2:361–367.
32. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R,
Brown W, Le M, Berggren R, Parks WT, Fang FC. 1999. Extraintestinal
dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:
804–808.
33. Jantsch J, Chikkaballi D, Hensel M. 2011. Cellular aspects of immunity
to intracellular Salmonella enterica. Immunol. Rev. 240:185–195.
34. Torzicky M, Viznerova P, Richter S, Strobl H, Scheinecker C, Foedinger
Lovelace et al.
1962 iai.asm.org Infection and Immunity
 o
n
 M
ay 8, 2014 by RM
IT UNIV
http://iai.asm
.org/
D
ow
nloaded from
 
D, Riedl E. 2012. Platelet endothelial cell adhesion molecule-1 (PECAM-
1/CD31) and CD99 are critical in lymphatic transmigration of human
dendritic cells. J. Investig. Dermatol. 132:1149–1157.
35. Bedoui S, Kupz A, Wijburg OL, Walduck AK, Rescigno M, Strugnell
RA. 2010. Differential bacterial pathogens, different strategies, yet the aim
is the same: evasion of intestinal dendritic cell recognition. J. Immunol.
184:2237–2242.
36. Woodfin A, Voisin MB, Noourshargh S. 2007. PECAM-1: a multi-
functional molecule in inflammation and vascular biology. Arterioscler.
Thromb. Vasc. Biol. 27:2514–2523.
37. Privratsky JR, Newman DK, Newman PJ. 2010. PECAM-1: conflicts of
interest in inflammation. Life Sci. 87:69–82.
38. Schenkel AR, Chew TW, Muller WA. 2004. Platelet endothelial cell
adhesion molecule deficiency or blockade significantly reduces leukocyte
emigration in a majority of mouse strains. J. Immunol. 173:6403–6409.
39. Richter-Dahlfors A, Buchan AM, Finlay BB. 1997. Murine salmonellosis
studied by confocal microscopy: Salmonella typhimurium resides intra-
cellularly inside macrophages and exerts a cytotoxic effect on phagocytes
in vivo. J. Exp. Med. 186:569–580.
40. Nauciel C, Espinasse-Maes F. 1992. Role of gamma interferon and tumor
necrosis factor alpha in resistance to Salmonella typhimurium infection.
Infect. Immun. 60:450–454.
41. Vazquez-Torres A, Fantuzzi G, Edwards CK, Dinarello CA, Fang FC.
2001. Defective localization of the NADPH phagocyte oxidase to Sal-
monella-containing phagosomes in tumor necrosis factor p55 recep-
tor-deficient macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:2561–
2565.
42. Everest P, Roberts M, Dougan G. 1998. Susceptibility to Salmonella
typhimurium infection and effectiveness of vaccination in mice deficient
in the tumor necrosis factor alpha p55 receptor. Infect. Immun. 66:3355–
3364.
43. Privratsky JR, Tilkens SB, Newman DK, Newman PJ. 2012. PECAM-1
dampens cytokine levels during LPS-induced endotoxemia by regulating
leukocyte trafficking. Life Sci. 90:177–184.
PECAM-1 Attenuates Oral S. Typhimurium Infection In Vivo
June 2013 Volume 81 Number 6 iai.asm.org 1963
 o
n
 M
ay 8, 2014 by RM
IT UNIV
http://iai.asm
.org/
D
ow
nloaded from
 
